Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

6.975 USD +0.075 (+1.09%)
Streaming Delayed Price Updated: 10:06 AM EST, Jan 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ardelyx Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
32 Stocks Moving In Tuesday's Mid-Day Session
Gainers Regional Health Properties, Inc. (NYSE: RHE) shares surged 56 percent to $0.3980. Precipio, Inc. (NASDAQ: ... 
Tags SAIL LBY AZO
From Benzinga
Mid-Day Market Update: Dycom Industries Falls On Q3 Miss; America's Car-Mart Shares Gain
Midway through trading Tuesday, the Dow traded down 0.09 percent to 24,990.98 while the NASDAQ climbed 0.15 percent to 7,404.87. The ... 
Tags News Benzinga GBNK
From Benzinga
Ardelyx Inc Falling Today on Above-Average Volume (ARDX)
The price of Ardelyx Inc shares has slipped to $4.55 (a 19.5% change) on heavy trading volume. Approximately 889,000 shares have changed hands today vs. average 30-day volume of... 
From Comtex SmarTrend® News Briefs
25 Stocks Moving In Tuesday's Pre-Market Session
Gainers Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market ... 
Tags Benzinga Movers & Shakers News
From Benzinga
Benzinga's Daily Biotech Pulse: Melinta, Ardelyx Pull Back On Offerings, Insys Awaits FDA Verdict
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks Hitting ... 
Tags HAE BSX ARDX
From Benzinga
8 Stocks Moving In Monday's After-Hours Session
Gainers Pernix Therapeutics Holdings Inc (NASDAQ: PTX) shares are up 10 percent reversing a 4 percent loss seen in the ... 
Tags Market News TCS PTX
From Benzinga
Ardelyx Raises $50 Million in Loan Agreement with Solar Capital and Bridge Bank
Ardelyx, Inc. (Nasdaq: ARDX), today announced it has entered into a $50.0 million senior secured term loan facility with Solar Capital Ltd. and the Life Sciences Group at Bridge Bank, a division of... 
From PR Newswire
Ardelyx Announces Proposed Public Offering of Common Stock
Ardelyx, Inc. (Nasdaq: ARDX), today announced that it has commenced an underwritten public offering of up to $50,000,000 of shares of its common stock. All of the shares to be sold in the offering will... 
From PR Newswire
Add Up The Pieces: SPSM Could Be Worth $35
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
BRIEF-Ardelyx Reports Qtrly Loss Per Share $0.36
* ARDELYX REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS 
Tags companyNews
From Reuters: Company News
Ardelyx Reports First Quarter 2018 Financial Results and Recent Business Highlights
On Track to Submit NDA for Tenapanor in IBS-C in Second Half of 2018 
From PR Newswire
Ardelyx Inc Down 12.1% Since SmarTrend Downtrend Call (ARDX)
SmarTrend identified a Downtrend for Ardelyx Inc (NASDAQ:ARDX) on February 13th, 2018 at $5.69. In approximately 3 months, Ardelyx Inc has returned 12.13% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
36 Biggest Movers From Yesterday
Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares climbed 84.87 percent to close at $2.20 on Wednesday. IZEA, Inc. ... 
Tags FRED DCAR ARDX
From Benzinga
Peek Under The Hood: PXSV Has 11% Upside
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Analysis: Positioning to Benefit within Euronet Worldwide, Innospec, Zosano Pharma, Ardelyx, Crown Castle International, and Aldeyra Therapeutics — Research Highlights Growth, Revenue, and Consolidate
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Euronet Worldwide, Inc.... 
From GlobeNewswire News Releases
First Week of ARDX May 18th Options Trading
Investors in Ardelyx Inc (ARDX) saw new options become available this week, for the May 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARDX options chain... 
Tags Stocks
From Market News Video
BRIEF-Knight Therapeutics Says ?Will Have Exclusive Rights To Market And Sell Tenapanor In Canada?
* KNIGHT THERAPEUTICS - ?LICENSE AGREEMENT WITH ARDELYX THAT PROVIDES KNIGHT WITH EXCLUSIVE RIGHTS TO COMMERCIALIZE TENAPANOR IN CANADA? 
Tags companyNews
From Reuters: Company News
Ardelyx and Knight Collaborate to Bring Tenapanor to Patients in Canada
License Agreement Advances First-in-Class Tenapanor for IBS-C and Hyperphosphatemia in Canada 
From PR Newswire
Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor
From Marketwired
Knight annonce une entente de licence exclusive avec Ardelyx pour la licence de Tenapanor
From Marketwired
Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor
Agreement Advances First-in-Class Tenapanor for IBS-C and Hyperphosphatemia in Canada 
From Marketwired News Releases
BRIEF-Ardelyx Reports Qtrly Earnings Per Share $0.21
* ARDELYX REPORTS 2017 FINANCIAL RESULTS AND APPOINTS INDUSTRY VETERAN, JAN LUNDBERG, PH.D., TO BOARD OF DIRECTORS 
Tags companyNews
From Reuters: Company News
Ardelyx Reports 2017 Financial Results and Appoints Industry Veteran, Jan Lundberg, Ph.D., to Board of Directors
Enrollment Underway in Second Registration Study of Tenapanor for Hyperphosphatemia 
From PR Newswire
Analysts Anticipate EQWS To Hit $49
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Consolidated Research: 2018 Summary Expectations for Progress Software, Cracker Barrel Old Country Store, Natural Grocers by Vitamin Cottage, VBI Vaccines, Ardelyx, and CytomX Therapeutics — Fundament
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Progress Software... 
From GlobeNewswire News Releases
Commit To Buy Ardelyx At $5, Earn 16.5% Annualized Using Options
Investors considering a purchase of Ardelyx Inc (ARDX) stock, but cautious about paying the going market price of $5.72/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
Ardelyx Announces Departure of Chief Scientific Officer
Ardelyx, Inc. (NASDAQ: ARDX) today announced that Jeremy Caldwell, Ph.D., chief scientific officer, will be leaving the company, effective February 16, 2018, to pursue a position as chief executive... 
From PR Newswire
Ardelyx to Participate in Leerink Partners 7th Annual Global Healthcare Conference
Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab, president and chief executive officer of Ardelyx, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference... 
From PR Newswire
Add Up The Pieces: PXSV Could Be Worth $33
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Uptrend Call Working As Ardelyx Inc Stock Rises 18.9% (ARDX)
SmarTrend identified an Uptrend for Ardelyx Inc (AMEX:ARDX) on November 29th, 2017 at $6.48. In approximately 2 months, Ardelyx Inc has returned 18.92% as of today's recent price of... 
From Comtex SmarTrend® News Briefs
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.